URO-1, Inc., an emerging company that develops solutions for office procedures in urology and urogynecology announced the issuance of US Patent, “Medical Injection Assemblies for OnabotulinumtoxinA Delivery and Methods of Use Thereof.” The invention relates to the company’s Repris™ Bladder Injection System.
May 15, 2019
· 1 min read